BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20357452)

  • 61. Conservative management of spontaneous ruptured hepatocellular carcinoma.
    Xu HS; Yan JB
    Am Surg; 1994 Aug; 60(8):629-33. PubMed ID: 8030822
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Systematic review of transarterial embolization for hepatocellular adenomas.
    van Rosmalen BV; Coelen RJS; Bieze M; van Delden OM; Verheij J; Dejong CHC; van Gulik TM
    Br J Surg; 2017 Jun; 104(7):823-835. PubMed ID: 28518415
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hepatocellular adenomas: current update on genetics, taxonomy, and management.
    Shanbhogue A; Shah SN; Zaheer A; Prasad SR; Takahashi N; Vikram R
    J Comput Assist Tomogr; 2011; 35(2):159-66. PubMed ID: 21412084
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Liver Transplantation for Treatment of Unresectable Spontaneous Ruptured Hepatocellular Adenoma: A Rare Indication.
    Rocha P; Leal N; Barbosa M; De Resende J; Rodrigues P
    Cureus; 2022 Aug; 14(8):e27788. PubMed ID: 36106301
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Management of hepatocellular adenoma: solitary-uncomplicated, multiple and ruptured tumors.
    Toso C; Majno P; Andres A; Rubbia-Brandt L; Berney T; Buhler L; Morel P; Mentha G
    World J Gastroenterol; 2005 Sep; 11(36):5691-5. PubMed ID: 16237767
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Spontaneous Hepatic Hemorrhage: A Single Institution's 16-Year Experience.
    Rosales A; Que FG
    Am Surg; 2016 Nov; 82(11):1117-1120. PubMed ID: 28206941
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Can a decision-making model be justified in the management of hepatocellular adenoma?
    van Aalten SM; Witjes CD; de Man RA; Ijzermans JN; Terkivatan T
    Liver Int; 2012 Jan; 32(1):28-37. PubMed ID: 22098685
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The role of liver transplantation for hepatic adenomatosis in the pediatric population: case report and review of the literature.
    Wellen JR; Anderson CD; Doyle M; Shenoy S; Nadler M; Turmelle Y; Shepherd R; Chapman WC; Lowell JA
    Pediatr Transplant; 2010 May; 14(3):E16-9. PubMed ID: 19490491
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A Scoping Review of the Classification, Diagnosis, and Management of Hepatic Adenomas.
    Aziz H; Brown ZJ; Eskander MF; Aquina CT; Baghdadi A; Kamel IR; Pawlik TM
    J Gastrointest Surg; 2022 Apr; 26(4):965-978. PubMed ID: 35083725
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Will weight loss become a future treatment of hepatocellular adenoma in obese patients?
    Dokmak S; Belghiti J
    Liver Int; 2015 Oct; 35(10):2228-32. PubMed ID: 26216699
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Hepatocellular adenoma: update 2020].
    Romailler É; Schmidt Kobbe S; Moradpour D; Sempoux C
    Rev Med Suisse; 2020 Sep; 16(704):1554-1559. PubMed ID: 32880111
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Hepatocellular adenoma as a cause of liver rupture and intrauterine foetal death].
    Olesen MS; Andersen LLT; Bjerring OS
    Ugeskr Laeger; 2021 Nov; 183(45):. PubMed ID: 34796860
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Snapshot summary of diagnosis and management of hepatocellular adenoma subtypes.
    Bioulac-Sage P; Sempoux C; Frulio N; Le Bail B; Blanc JF; Castain C; Laurent C; Trillaud H; Chiche L; Balabaud C
    Clin Res Hepatol Gastroenterol; 2019 Feb; 43(1):12-19. PubMed ID: 30213653
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Safety and efficacy of transarterial embolization of hepatocellular adenomas.
    van Rosmalen BV; Klompenhouwer AJ; de Graeff JJ; Haring MPD; de Meijer VE; Rifai L; Dokmak S; Rawashdeh A; Abu Hilal M; de Jong MC; Dejong CHC; Doukas M; de Man RA; IJzermans JNM; van Delden OM; Verheij J; van Gulik TM;
    Br J Surg; 2019 Sep; 106(10):1362-1371. PubMed ID: 31313827
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Liver transplantation for treatment of giant hepatocellular adenomas.
    Mueller J; Keeffe EB; Esquivel CO
    Liver Transpl Surg; 1995 Mar; 1(2):99-102. PubMed ID: 9346548
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bleeding hepatic adenoma: expectant treatment to limit the extent of liver resection.
    Heeringa B; Sardi A
    Am Surg; 2001 Oct; 67(10):927-9. PubMed ID: 11603546
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Current Approaches in the Management of Hepatic Adenomas.
    Tsilimigras DI; Rahnemai-Azar AA; Ntanasis-Stathopoulos I; Gavriatopoulou M; Moris D; Spartalis E; Cloyd JM; Weber SM; Pawlik TM
    J Gastrointest Surg; 2019 Jan; 23(1):199-209. PubMed ID: 30109469
    [TBL] [Abstract][Full Text] [Related]  

  • 78. LATE SURGICAL TREATMENT FOR SPONTANEOUS RUPTURE OF HEPATOCELLULAR ADENOMA: CASE REPORT.
    Pinto LE; Silva JP; Rêgo GC; Garcia JH
    Arq Bras Cir Dig; 2015; 28(4):297-9. PubMed ID: 26734808
    [No Abstract]   [Full Text] [Related]  

  • 79. [Multiple large hepatocellular adenomas in a patient with glycogen storage disease type Ia].
    Uemura S; Ariizumi S; Takahashi Y; Omori A; Kotera Y; Katagiri S; Hashimoto E; Nakano M; Yamamoto M
    Nihon Shokakibyo Gakkai Zasshi; 2014 Apr; 111(4):787-96. PubMed ID: 24769469
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Hepatocellular adenoma - new classification and recommendations].
    Aamann L; Schultz N; Fallentin E; Hamilton-Dutoit S; Vogel I; Grønbæk H
    Ugeskr Laeger; 2015 Mar; 177(12):V07140397. PubMed ID: 25786843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.